Stock 300434 SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sichuan Goldstone Asia Pharmaceutical Inc.

Equities

300434

CNE100001YX5

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
9.03 CNY +2.27% Intraday chart for Sichuan Goldstone Asia Pharmaceutical Inc. +10.53% -18.35%
25/04 Sichuan Goldstone Asia Pharmaceutical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Hangzhou Solipharma Technology Development Co., Ltd. announced that it expects to receive CNY 69.4857 million in funding from Sichuan Goldstone Asia Pharmaceutical Inc., Hangzhou Huolongguo Investment Management Co., Ltd. and another investor CI

Business Summary

Sichuan Goldstone Asia Pharmaceutical Inc., formerly Sichuan Goldstone Orient New Material Equipment Inc, is a China-based company principally engaged in the production and sales of pharmaceutical products, as well as drug agency business. Its main products include health products, cracks and small cracks. The Company is also engaged in the machinery manufacturing business, as well as property leasing and management business. Its machinery products mainly include steel reinforced plastic pipe production line, bead winding steel reinforced pipe production line, production line equipment parts and other equipment. The Company mainly operates its businesses in domestic market.

Number of employees: 1,878

Sales per Business

CNY in Million2021Weight2022Weight Delta
Crack, Small Crack
58.6 %
529 50.2 % 728 58.6 % +37.63%
Other Pharmaceutical Products
14.5 %
126 12.0 % 180 14.5 % +42.27%
OEM and Wholesale and Retail Pharmaceuticals
12.3 %
138 13.1 % 152 12.3 % +10.82%
Complete Production Line
7.9 %
176 16.7 % 98 7.9 % -44.66%
Real Estate Leasing and Management
3.4 %
46 4.3 % 42 3.4 % -8.32%
Health Product
2.1 %
26 2.5 % 27 2.1 % +1.83%
Mechanical Parts and Others
0.9 %
9 0.8 % 11 0.9 % +31.85%
Vertical Circulating Stereo Parking Equipment
0.4 %
4 0.4 % 5 0.4 % +28.34%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
99.1 %
1,049 99.6 % 1,231 99.1 % +17.34%
Overseas
0.9 %
5 0.4 % 12 0.9 % +158.15%

Managers

Managers TitleAgeSince
Bao Kang Wei CEO
 Chief Executive Officer 56 09/19/09
Qing Guo Wang DFI
 Director of Finance/CFO 49 25/22/25
Zhi Yong Zheng BRD
 Director/Board Member 56 13/17/13
Qiang Lin BRD
 Director/Board Member 60 01/04/01
Yi Xi Kuai BRD
 Director/Board Member 66 01/04/01
Xin He IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Jin Lou BRD
 Director/Board Member 94 13/17/13
Bao Kang Wei CEO
 Chief Executive Officer 56 09/19/09
Yi Xi Kuai BRD
 Director/Board Member 66 01/04/01
Run Xiu Li BRD
 Director/Board Member 55 01/04/01
Jian Wei Zhu BRD
 Director/Board Member 69 18/20/18
Zhi Yong Zheng BRD
 Director/Board Member 56 13/17/13
Wen Jie Ma BRD
 Director/Board Member 42 13/17/13
Liu Yang BRD
 Director/Board Member 39 13/17/13
Li Li Wang BRD
 Director/Board Member 47 13/17/13
Sheng Xuan Jin BRD
 Director/Board Member 48 26/23/26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 401,743,872 156,631,424 ( 38.99 %) 0 38.99 %

Shareholders

NameEquities%Valuation
Zhi Yong Zheng
0.4517 %
906,726 0.4517 % 1 M ¥
Bosera Asset Management Co., Ltd.
0.2349 %
471,600 0.2349 % 576 819 ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
0.0254 %
51,000 0.0254 % 62 379 ¥
Everbright Securities Asset Management Co., Ltd.
0.0228 %
45,700 0.0228 % 55 896 ¥
Broad Fund Management Co. Ltd.
0.0188 %
37,700 0.0188 % 46 111 ¥
Jyah Asset Management Co. Ltd.
0.0156 %
31,300 0.0156 % 38 283 ¥
BOC International China Ltd. (Investment Management)
0.0114 %
22,900 0.0114 % 28 009 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.009664 %
19,400 0.009664 % 23 728 ¥
GF Fund Management Co., Ltd.
0.008668 %
17,400 0.008668 % 21 282 ¥
Shanghai Guotai Junan Securities Assets Management Co., Ltd.
0.006526 %
13,100 0.006526 % 16 023 ¥

Company contact information

Sichuan Goldstone Asia Pharmaceutical, Inc.

8/F, Area A1 Dadi New Guanghua Plaza

610072, Chengdu

+

http://www.goldstone-group.com
address Sichuan Goldstone Asia Pharmaceutical Inc.(300434)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC. Stock Sichuan Goldstone Asia Pharmaceutical Inc.
-18.35% 501M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.62% 43.67B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.67% 22.51B
SANDOZ GROUP AG Stock Sandoz Group AG
+14.56% 14.6B
CIPLA LIMITED Stock Cipla Limited
+14.22% 13.74B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+42.62% 11.91B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.37% 7.04B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+10.21% 5.42B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300434 Stock
  4. Company Sichuan Goldstone Asia Pharmaceutical Inc.